Jazz Pharma (JAZZ.US) Stock Community - Hot Topic Discussions

Quote List Quote List

Event Tracking

Dec17

Jazz Pharma to Hold Investor Webcast on Zanidatamab Phase 3 Trial Results

21:15

Dec14

Jazz Pharmaceuticals Reports Positive Clinical Updates for Epidiolex and Ziihera

23:43

Dec9

Jazz Pharmaceuticals' VP and CAO Patricia Carr Sells Shares

22:32

Jazz Pharmaceuticals' Senior Vice President Disposes of Common Stock

22:26

Jazz Pharmaceuticals Displays Xywav® Efficacy Data for Treating Narcolepsy

15:06

Dec7

Schroder Investment Management Group Increased Holdings in Jazz Pharmaceuticals by 90.1%

10:19

Schedules & Filings

Schedules

Filings

Nov5

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 1.126 B, Net Income 251.41 M, EPS 4.08

Aug5

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 1.046 B, Net Income -718.47 M, EPS -11.7408

May6

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 897.84 M, Net Income -92.54 M, EPS -1.5175

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change